Australia's largest stock trading and investment forum Australia's #1 stock forum

NEU

Click for more information

0.19%

$20.69 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-9

First 9 Last

Share
Profile

Follow
Potstock88

425 Posts.

146

13/12/21

16:42

Post #: 58261771
Share

Originally posted by hottod: ↑

I think that MST Access is more likely to be right on this, as it was engaged by Neuren. MST states that the ACAD agreement includes “payments over CY22/23 on FDA approval and market entry”.

Also, in the results conference last week, Jon Pilcher talked about expected payments based on the assumption that the FDA approves trofinetide and that the product is launched.

It’s possible that NDA filing will trigger a payment, but it looks likely that the first payment will be due on FDA approval which, if all goes well, could be next November or December.

Expand

Hi hottod. I refer you to the webcast where JP is speaking. He makes it quite clear that the first milestone payment will be in early 2022.

NEU Price at posting: $4.01 Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 976 more messages in this thread...

First 9 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $20.69		Change -0.040(0.19%)		Mkt cap ! $2.667B

Open	High	Low	Value	Volume
$20.90	$21.30	$20.54	$2.234M	106.9K

Buyers (Bids)

No.	Vol.	Price($)
10	227	$20.68

Sellers (Offers)

Price($)	Vol.	No.
$20.70	106	6

View Market Depth

No.	Vol.	Price($)
4	112	20.690
4	133	20.680
4	270	20.670
2	208	20.660
2	202	20.650

Price($)	Vol.	No.
20.700	57	6
20.710	167	4
20.720	244	3
20.730	284	5
20.740	202	2

Last trade - 12.50pm 22/05/2024 (20 minute delay)


Last $20.68			Change -0.040 ( 0.39 %)
Open	High		Low	Volume
$20.93	$21.30		$20.55	42297
Last updated 13.10pm 22/05/2024 ?

NEU (ASX) Chart

SPONSORED BY